Myelogenous Leukemia, Chronic
6 clinical trials · Condition
◉ Watch Myelogenous Leukemia, Chronic
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (NCT01503502) | Jiangsu HengRui Medicine Co., Ltd. | 2011-08-01 |
| A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) (NCT00471497) | Novartis Pharmaceuticals | 2007-07-31 |
| MK0457 in Patients With Leukemia (0457-003) (NCT00111683) | Merck Sharp & Dohme LLC | 2005-06-01 |
| Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML) (NCT02736721) | Hoffmann-La Roche | 2003-09-01 |
| Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML) (NCT00038597) | M.D. Anderson Cancer Center | 2001-04-30 |
| Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) (NCT00179764) | Ann & Robert H Lurie Children's Hospital of Chicago | 2000-03-10 |
Track Myelogenous Leukemia, Chronic automatically
Every clearance here is in the API, with alerts when new ones post.